C9176 – Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose

Long description

Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose

Short description

Dom nonheu tc99m add-on/dose

Pricing indicator

53 Statute

Medicare coverage

D Special coverage instructions apply

BETOS category

Y1 Other - Medicare fee schedule

ASC

Approved for ambulatory surgical centers

Added

January 1, 2026

Last change

January 1, 2026 – No change

Nearby C codes

• C9168 – Injection, mirikizumab-mrkz, 1 mg
• C9169 – Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
• C9170 – Injection, tarlatamab-dlle, 1 mg
• C9171 – Injection, pegulicianine, 1 mg
• C9172 – Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
• C9173 – Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
• C9174 – Injection, datopotamab deruxtecan-dlnk, 1 mg
• C9175 – Injection, treosulfan, 50 mg
• C9248 – Injection, clevidipine butyrate, 1 mg
• C9250 – Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml
• C9254 – Injection, lacosamide, 1 mg
• C9257 – Injection, bevacizumab, 0.25 mg
• C9275 – Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose
• C9285 – Lidocaine 70 mg/tetracaine 70 mg, per patch
• C9290 – Injection, bupivacaine liposome, 1 mg
• C9293 – Injection, glucarpidase, 10 units